Publications by authors named "W Thienphrapa"

Recent studies have demonstrated that anti-staphylococcal beta-lactam antibiotics, like nafcillin, render methicillin-resistant Staphylococcus aureus (MRSA) more susceptible to killing by innate host defense peptides (HDPs), such as cathelicidin LL-37. We compared the effects of growth in 1/4 minimum inhibitory concentration (MIC) of nafcillin or vancomycin on the LL-37 killing of 92 methicillin-susceptible S. aureus (MSSA) isolates.

View Article and Find Full Text PDF
Article Synopsis
  • Coxsackieviruses (CVs) are common viruses linked to serious diseases like myocarditis and meningo-encephalitis, and they can persist in host tissues while evading the immune response.
  • Historically classified as non-enveloped, recent findings indicate that CVs can acquire an envelope from host membranes, which may enhance their resistance to antibodies and promote viral spread.
  • The article reviews advancements in understanding CV replication, tropism towards progenitor cells (explaining higher susceptibility in the young), and their strategies for immune evasion, while also addressing remaining questions and potential future research areas.
View Article and Find Full Text PDF

The marine natural product, marinopyrrole A (1), was previously shown to have significant antibiotic activity against Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). Although compound (1) exhibits a significant reduction in MRSA activity in the presence of human serum, we have identified key modifications that partially restore activity. We previously reported our discovery of a chloro-derivative of marinopyrrole A (1a) featuring a 2-4 fold improved minimum inhibitory concentration (MIC) against MRSA, significantly less susceptibility to serum inhibition and rapid and concentration-dependent killing of MRSA.

View Article and Find Full Text PDF

Anthracimycin is a recently discovered novel marine-derived compound with activity against Bacillus anthracis. We tested anthracimycin against an expanded panel of Staphylococcus aureus strains in vitro and in vivo. All strains of S.

View Article and Find Full Text PDF

Unlabelled: Based on in vitro synergy studies, the addition of nafcillin to daptomycin was used to treat refractory methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. Daptomycin is a de facto cationic antimicrobial peptide in vivo, with antistaphylococcal mechanisms reminiscent of innate host defense peptides (HDPs). In this study, the effects of nafcillin on HDP activity against MRSA were examined in vitro and in vivo.

View Article and Find Full Text PDF